Plain-English translation of NCT06885619 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
After a heart attack, doctors need better ways to predict which patients will develop serious heart problems later on. This study is testing whether advanced blood analysis—looking at many different substances and immune markers in the blood—can identify patients at higher risk of poor outcomes. Researchers will collect blood samples from 1,000 people who have had a heart attack and track them for six months to see if these new blood tests are more accurate than current methods.
Even with modern heart attack treatment, many patients develop a condition where the heart weakens and loses its ability to pump effectively, leading to heart failure and life-threatening complications. Current blood tests used after a heart attack don't do a good job of predicting who will have these problems, so doctors need better tools to identify at-risk patients early.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will have blood drawn multiple times starting within 24 hours after your emergency heart procedure and continuing through a six-month follow-up period. You will also have heart ultrasounds (echocardiograms) to measure how well your heart is pumping. The researchers will analyze your blood samples using advanced laboratory techniques to look for patterns that might predict whether your heart will weaken or develop complications. Your participation helps doctors develop better tools to predict recovery and identify patients who need closer monitoring or more aggressive treatment.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
China
Sponsor
Beijing Anzhen Hospital
Collaborators
Beijing Jishuitan Hospital, Institute of Biophysics, Chinese Academy of Sciences
Enrollment target
~1,000 participants
Started
May 2025
Primary completion
December 2027
Age range
18 Years – 80 Years
Last updated on clinicaltrials.gov in May 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Xu Wang, Dr.
Beijing Anzhen hospital, Capital Mediacl University.
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.